Knowledge about schizophrenia test: the Chinese Mandarin version and its sociodemographic and clinical factors

BMC Psychiatry. 2023 Jul 24;23(1):535. doi: 10.1186/s12888-023-04822-9.

Abstract

Background: Schizophrenia is a chronic, complex, and severe mental disorder and caregivers having knowledge about it can help improve patient adherence to treatment. This study aims to translate the Knowledge About Schizophrenia Test (KAST) into a Chinese Mandarin version and test it among caregivers to validate its reliability and reproducibility, as well as to determine its associated sociodemographic factors and clinical factors.

Methods: The project surveyed 160 patients with schizophrenia and their caregivers at four community health facilities in Beijing, China, from January 2022 to February 2022. All patients and caregivers completed the sociodemographic questionnaire, and caregivers also completed the Chinese-version KAST, and 143 of these caregivers completed the Chinese-version KAST again 2-4 weeks later.

Results: The mean (SD) of the caregiver score was 11.49 (± 3.13). After item analysis, there was acceptable internal consistency among the 17 items in the Chinese version (KR-20 coefficient 0.702). The intraclass correlation coefficient in the retest (0.686) was statistically significant. Gender, educational attainment, marital status, relationship with the patient, and occupational status were associated with the KAST score.

Conclusion: The findings demonstrate that the Chinese-version KAST is a reliable and reproducible instrument that can measure knowledge about schizophrenia and is valid to be applied in schizophrenia research.

Keywords: Caregivers; Chinese-version; Knowledge about Schizophrenia Test; Schizophrenia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Caregivers
  • China
  • Humans
  • Psychometrics
  • Reproducibility of Results
  • Schizophrenia* / diagnosis
  • Schizophrenia* / therapy
  • Surveys and Questionnaires